This study was designed to assess the effects of the ARB, losartan, compared with the CCB, amlodipine, on LV diastolic function and atherosclerosis of the carotid artery in Japanese patients with mild ...

Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure medications. All of the recalls are due to the finding of N-Methylnitrosobutyric acid above the acceptable ...

Approximately 43 million people in Japan suffer from hypertension. 1 The majority require a combination of antihypertensive drugs to achieve adequate blood pressure (BP) control. A cross-sectional ...

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens. July 13, ...

Teva Pharmaceuticals has launched a voluntary recall into two drugs used to treat high blood pressure as yet more medications face concerns over a possible cancer risk. In a statement from Teva posted ...